PMI Launches IQOS ILUMA in Emerging Markets
Recently, Philip Morris International (PMI) launched its heated tobacco product IQOS ILUMA in multiple emerging markets worldwide, as well as a limited edition version called IQOS ILUMA STARDRIFT with innovative design features in several mature markets.
PMI has introduced IQOS ILUMA in seven different countries in emerging markets, spanning Europe, Asia, and the Americas. These countries include Bulgaria, Malaysia, Bosnia and Herzegovina, Macedonia, Montenegro, Guatemala, and Morocco. It is noteworthy that Macedonia, Bosnia and Herzegovina, Montenegro, and Bulgaria are located in southeastern Europe, in close proximity to PMI's factory in Italy.
Meanwhile, IQOS ILUMA STARDRIFT has also been launched in mature markets such as South Korea, Spain, and Romania.
Philip Morris International (PMI) is focusing on the US market and has recently submitted a premarket tobacco product application (PMTA) and a modified risk tobacco product application (MRTPA) for IQOS ILUMA to the Food and Drug Administration (FDA) in late October. This move is an important step towards the official launch of their product in the US market.
Furthermore, PMI is currently seeking trademark registration for "VEEV One Ultra" and "VEEV Now Ultra" at the Korean Patent Office, indicating that the company may have plans to launch its vape product VEEV in the Korean market in the future.
In its latest quarterly report, PMI announced a remarkable achievement of surpassing $9 billion in net income for the first time, with the success of IQOS being one of the key factors. The report reveals that the shipment volume of heated tobacco products, including e-cigarettes, increased by 18% compared to the previous quarter. PMI is actively driving innovation and market expansion to bolster its performance globally.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
